Position in NVS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$8,554
New position
Shares Held
56
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Lloyd Advisory Services, LLC. holds $1,085,044 across 10 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
1,113 | $280,075 | |
| 2 | PFE |
Pfizer Inc
|
9,335 | $224,786 | |
| 3 | SNY |
Sanofi
|
5,244 | $223,709 | |
| 4 | MRK |
Merck & Co., Inc.
|
901 | $115,778 | |
| 5 | AMGN |
Amgen Inc
|
314 | $113,705 | |
| 6 | JNJ |
Johnson & Johnson
|
259 | $65,778 | |
| 7 | LLY |
ELI LILLY & Co
|
32 | $38,381 | |
| 8 | AZN |
Astrazeneca PLC
|
105 | $19,910 |
All Filings in NVS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,554 | 56 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||